Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary

In recent years, international academics recognized that quality-adjusted life-years (QALYs) may not always fully capture the benefits produced by an intervention, and considered incorporating additional elements of value into cost-effectiveness analysis (CEA). Examples of these elements are adheren...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lihua, Li, Shiqi, Peng, Xiaochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613353/
https://www.ncbi.nlm.nih.gov/pubmed/37898809
http://dx.doi.org/10.1186/s12962-023-00490-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613353/
https://www.ncbi.nlm.nih.gov/pubmed/37898809
http://dx.doi.org/10.1186/s12962-023-00490-4

Ejemplares similares